Page 28 - Service Testing News Today

Health-care companies were flat as traders sought out sectors less susceptible to the negative impacts of inflation. Moderna shares rallied after the vaccine...

By Colin Kellaher Lyra Therapeutics on Tuesday said a Phase 2 study of its LYR-220 drug candidate met its primary endpoint in certain patients with chronic...

By Colin Kellaher Lyra Therapeutics shares moved higher in premarket trading Tuesday after the clinical-stage biotechnology company reported a successful...

By Sabela Ojea Eiger BioPharmaceuticals said it is discontinuing the company's phase 3 study to treat peginterferon lambda in patients with chronic hepatitis...

By Ben Glickman Rocket Pharmaceuticals said it had reached alignment with the Food and Drug Administration on its Phase 2 trial of its treatment for Danon...

By Ben Glickman AstraZeneca said Monday that a Phase 3 trial of its treatment for eosinophilic granulomatosis with polyangiitis, a rare form of vasculitis,...

By Ben Glickman Shares of Acelyrin fell after-hours after the company said its skin drug candidate's primary endpoint didn't meet statistical significance....

By Colin Kellaher Shares of CymaBay Therapeutics surged in premarket trading Thursday after the biopharmaceutical company said a Phase 3 study of its...

By Sabela Ojea Shares of Clearmind Medicine climbed Wednesday after the company said it has signed its first human clinical trial agreement with Johns...

By Chris Wack Portage Biotech has entered into a clinical trial collaboration agreement with Merck to evaluate Portage's next-generation adenosine...